The IDIGH Program Management Committee consists of representatives from all three pillars of the program (fundamental research, epidemiology & health outcome and clinical research), external (non-IDIGH program) members and trainees. Our committee meets 3-4 times/year to address issues related to the program and to discuss strategies and action points to move  the IDIGH program forward towards its objective of becoming a world leading centre for translational research in infectious and immune-mediated diseases of global importance.

 

 IDIGH Program Management Meeting. Photo by Jing Liu
IDIGH Program Management Meeting. Photo by Jing Liu

Management

Dr. Erwin Schurr (Program Leader)
Dr. Marcel Behr (Associate Program Leader)

Representatives of fundamental research

Dr. Nicole Bernard
Dr. Ciriaco Piccirillo

Representatives of epidemiology & health outcome research

Dr. Theresa Gyorkos
Dr. Marina Klein
Dr. Madhukar Pai

Representatives of clinical research

Dr. Don Sheppard
Dr. Marcel Behr

Representatives of graduate students and post-doctoral fellows

Lauren Nagel (co-president of the IDIGH trainee committee)
Tho-Alfakar Al-Aubodah (co-president of the IDIGH trainee committee)

External (non-IDIGH program) members

Dr. Maziar Divangahi
TBD

IDIGH Calendar

<<  <  September 2020  >  >>
 Mo  Tu  We  Th  Fr  Sa  Su 
   1  2  3  4  5  6
  7  8  910111213
14151617181920
21222324252627
282930    

Latest IDIGH Publications

  1. Luz, P. M., Torres, T. S., Almeida-Brasil, C. C., Marins, L. M. S., Veloso, V. G., Grinsztejn, B., Cox, J. & Moodie, E. E. M.
    (2020)
    .
    High-Risk Sexual Behavior, Binge Drinking and Use of Stimulants are Key Experiences on the Pathway to High Perceived HIV Risk Among Men Who Have Sex with Men in Brazil
    .
    AIDS and behavior
  2. Sulis, G., Daniels, B., Kwan, A., Gandra, S., Daftary, A., Das, J. & Pai, M.
    (2020)
    .
    Antibiotic overuse in the primary health care setting: a secondary data analysis of standardised patient studies from India, China and Kenya
    .
    BMJ global health
    ,
    vol
    .
    5
  3. Rebeiro, P. F., Jenkins, C. A., Bian, A., Lake, J. E., Bourgi, K., Moore, R. D., Horberg, M. A., Matthews, W. C., Silverberg, M. J., Thorne, J., Mayor, A. M., Lima, V. D., Palella, F. J., Saag, M. S., Althoff, K. N., Gill, M. J., Wong, C., Klein, M. B., Crane, H. M., Marconi, V. C., Shepherd, B. E., Sterling, T. R. & Koethe, J. R.
    (2020)
    .
    Risk of Incident Diabetes Mellitus, Weight Gain, and their Relationships with Integrase Inhibitor-based Initial Antiretroviral Therapy Among Persons with HIV in the US and Canada
    .
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  4. Mendel, A., Ennis, D., Go, E., Bakowsky, V., Baldwin, C., Benseler, S. M., Cabral, D. A., Carette, S., Clements-Baker, M., Clifford, A., Cohen Tervaert, J. W., Cox, G., Dehghan, N., Dipchand, C., Dhindsa, N., Famorca, L., Fifi-Mah, A., Garner, S., Girard, L.-P., Lessard, C., Liang, P., Noone, D., Makhzoum, J.-P., Milman, N., Pineau, C. A., Reich, H. N., Rhéaume, M., Robinson, D. B., Rumsey, D. G., Towheed, T. E., Trudeau, J., Twilt, M., Yacyshyn, E., Yeung, R., Barra, L., Khalidi, N. & Pagnoux, C.
    (2020)
    .
    CanVasc consensus recommendations for the management of antineutrophil cytoplasm antibody-associated vasculitis: 2020 update
    .
    The Journal of rheumatology
  5. Lee, T. C., Wilson, M. G., Lawandi, A. & McDonald, E. G.
    (2020)
    .
    Proton pump inhibitors vs. histamine-2 receptor antagonists likely increase mortality in critical care: an updated meta-analysis
    .
    The American journal of medicine
More publications